5-(1,3,4-oxadiazol-2-yl)-1h-indazole and...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/04 (2006.01) A61K 31/433 (2006.01) A61P 3/04 (2006.01) A61P 3/06 (2006.01) A61P 3/10 (2006.01) C07D 417/04 (2006.01)

Patent

CA 2675735

Disclosed are novel aminoindazole urea derivatives of formula (I), wherein L, X, Y, R3, R4 and R5 have the meanings indicated in claim 1. Said aminoindazole urea derivatives are SGK inhibitors and can be used for the treatment of SGK-induced diseases and ailments such as diabetes, obesity, metabolic syndrome (dyslipidemia), systemic and pulmonary hypertension, cardiovascular diseases, and kidney diseases, more generally for any kind of fibroses and inflammatory processes.

L'invention concerne de nouveaux dérivés d'urée d'aminoindazole de formule (I), où L, X, Y, R3, R4 et R5 ont les significations indiquées dans la revendication 1. Ces nouveaux dérivés sont des inhibiteurs de la SGK et peuvent être utilisés pour le traitement de maladies et affections liées à la SGK comme le diabète, l'obésité, le syndrome métabolique (dyslipidémie), l'hypertonie généralisée et pulmonaire, les maladies cardio-vasculaires et les maladies rénales, et d'une manière générale pour tous types de fibroses et de processus inflammatoires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

5-(1,3,4-oxadiazol-2-yl)-1h-indazole and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-(1,3,4-oxadiazol-2-yl)-1h-indazole and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-(1,3,4-oxadiazol-2-yl)-1h-indazole and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2065554

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.